“TNFi, IL17i, JAKi--- note that these are the only classes of drug that work for axial spondyloarthritis!” – Dr. @AlexisOgdie noted ustekinumab, apremilast, and abatacept do not work for inflammatory back pain. @rheumnow #RLN2024 https://t.co/BHV6qCUdYi